MIT Tech Review: AI Accelerates Drug Design and Autonomous Discovery Labs
nordicinst · x · 2026-07-23
MIT Technology Review explores the deep application of AI in biotechnology. AI is significantly accelerating drug design, targeting complex multi-disease biology, and helping build autonomous discovery labs. European giants are pushing frontier biotech, proving machines can help cure humans while keeping human experts in the loop.
More from Research
- Paper: data schedules and learning rate schedules should be designed together — alifcoder · 2026-10-27
- Health benchmark study: quality and diversity of eval items beat quantity — keunwoochoi · 2026-10-27
- Across 7 tasks, highest reasoning setting isn't the best for most open models — keunwoochoi · 2026-10-27
- Open Models Match GPT-6 on MedMCQA but Trail 17 Points on Hard Clinical Cases — keunwoochoi · 2026-10-27
- Data Curriculum and LR Schedule Should Be Co-Designed: Math Data Placement Flips With Learning Rate — CatAstro_Piyush · 2026-10-27
- Health-Focused Benchmark Reranks LLMs: Muse Spark Open Jumps from #9 to #1 — keunwoochoi · 2026-10-27